ANN ARBOR, Mich.--(BUSINESS WIRE)--AgelessRx, a leader in longevity telehealth solutions, announced the results of its 12-month, Participatory Evaluation of Aging with Rapamycin for Longevity (PEARL) ...

"Low-dose, intermittent rapamycin administration over 48 weeks is relatively safe in healthy, normative-aging adults, and was associated with significant improvements in lean tissue mass and pain in ...

A drug used to prevent organ rejection in kidney transplant patients is being touted for potentially slowing down aging. The immune-suppressing medication rapamycin, also known as sirolimus, is being ...

Although it’s true that average life expectancy is increasing, this increase is not driven by healthy years lived. Instead, it’s mostly driven by an increase in unhealthy years lived. As the disease ...